Beta Bionics

Healthcare ITSeries EIrvine, USbetabionics.com

Latest round

Series E

Last raised

Nov 2024

Total raised

$336M

Investors

16

About Beta Bionics

Based in the US, Beta Bionics, Inc.Beta Bionics, Inc. operates in the diabetes management sector, primarily known for its iLet Bionic Pancreas. Founded in 2015 in Irvine, US, the company has executed 11 deals to date.00 mn.Beta Bionics is primarily recognized for its flagship product, the iLet Bionic Pancreas, an insulin delivery system designed to autonomously manage diabetes for individuals with type 1 diabetes. The iLet operates by integrating with continuous glucose monitors (CGMs), such as the Dexcom CGM or FreeStyle Libre 3 Plus sensor, to continuously assess insulin requirements and administer precise doses without requiring the user to perform carb counting or adjustments manually. The latest iteration, the Color iLet, features an enhanced display with color graphics and audible alerts, aiming to improve user experience and engagement.Beta Bionics generates revenue through direct sales of its iLet Bionic Pancreas systems to consumers, facilitated by prescriptions from healthcare providers. The pricing structure involves a one-time purchase of the iLet device, alongside potential recurring revenue from consumables such as insulin delivery supplies and maintenance services. The company's model is predominantly B2C, targeting end users who require ongoing diabetes management solutions.In January 2025, Beta Bionics, Inc.

Who invested in Beta Bionics

16 investors across 6 rounds

See all investors in Beta Bionics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series E

    Nov 13, 2024

    Amount

    $60M

    Investors

    Locked

  2. Series D

    Aug 30, 2023

    Amount

    $100M

    Investors

    Locked

  3. Series C

    Feb 17, 2022

    Amount

    $57M

    Investors

    Locked

  4. Series B

    Jul 1, 2019

    Amount

    $63M

    Investors

    Locked

  5. Series B

    Oct 22, 2018

    Amount

    $7.5M

    Investors

    Locked

  6. Series B

    Aug 30, 2018

    Amount

    $48M

    Investors

    Locked

Questions about Beta Bionics

Who invested in Beta Bionics?

Beta Bionics has 16 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Beta Bionics raised?

Beta Bionics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did Beta Bionics last raise money?

Beta Bionics's most recent round on record is a Series E, in Nov 2024.

What does Beta Bionics do?

Based in the US, Beta Bionics, Inc.

Where is Beta Bionics headquartered?

Beta Bionics is headquartered in Irvine, US.

Which VCs invest in companies like Beta Bionics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Beta Bionics's stage. Their profiles are linked below.

Raising like Beta Bionics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.